Manorama Industries Approves ₹75 Crore Capital Infusion Across Wholly-Owned Global Subsidiaries
Manorama Industries Ltd · Change in Management · 05 Sept 2026, 1:55 am
Manorama Industries Approves ₹75 Crore Capital Infusion Across Wholly-Owned Global Subsidiaries Manorama Industries' board approved a total capital infusion of up to ₹75 Cr across six wholly-owned global subsidiaries to fund working capital and operational growth. Allocations include up to ₹20 Cr in Ghana, ₹15 Cr each in Burkina Faso and Brazil, ₹10 Cr each in Nigeria and Chad, and ₹5 Cr in UAE. Additionally, the board approved the appointment of Dr. Rohini Tiwari as Non-Executive Independent Director for five years from 4th Sep'26 to 3rd Sep'31, succeeding Mr. Mudit Kumar Singh whose tenure ended on 5th Sep'26.
Original exchange filing (PDF)
More announcements from Manorama Industries Ltd
- Transcript of Q2 & H1 FY27 Earnings Conference Call held on Friday, November 13, 2026. · 17 Nov 2026
- Intimation of Investor meet scheduled to be held on Wednesday, November 18, 2026. · 13 Nov 2026
- Intimation of Audio recording of the Q2 & H1 FY27 Earnings Conference Call with Analyst /Investors held on Friday, November 13, 2026 · 13 Nov 2026
- Investor Presentation · 13 Nov 2026
- Press Release · 13 Nov 2026
- Monitoring Agency Report · 13 Nov 2026
- Statement of Deviation and Variation · 13 Nov 2026
- Outcome of Board Meeting dated November 12, 2026 · 13 Nov 2026
